Although the stock price didn't reflect the news (it was a bad day for the market too), I was really glad to see that the company in on track with their plans for fast FDA approvals and that FDA is giving the green light for quick Optina trials. That re-iterates what AMPE's Management has been saying all along, which is to develop block buster drugs with fast, much less costly trials and speedy FDA approvals. So far Ampio's Management have delivered on what they've promised, so add another check mark if you're keeping track. Glad to also see they have $25 Million in the bank to complete these trials too. Go AMPE!!!
I agree, AMPE has one of the most promising pipelines of any small pharma today. With most of the drugs being already FDA approved once AMPE shows data from the trials, the new dosages, patented by AMPE are sure to be approved. We may see some swings in the next few weeks but AMPE has a lot to release in the next 6 months. At this price, a new position would have a good chance to make a heck of a gain. I sold PCYC after one of the best gains I have ever had and plan to repeat it with AMPE. I remember when the shorts pounded PCYC when it was $5, now it's over $50 and made a lot of people a lot of money. AMPE will start to get a lot of coverage as the trials unfold this year. Good luck to all!!!